Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Worldwide Offices
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Invictus Pharmacy First to Accept Crypto for Prescriptions

This image opens in the lightbox

News provided by

Invictus Pharmacy

13 Nov, 2025, 13:30 GMT

Share this article

Share toX
SHARE A PRE-MADE POST

Share this article

Share toX
SHARE A PRE-MADE POST

Disrupting pharmacy payments with ETH, SOL, and XRP acceptance nationwide; online rollout set for Jan. 1, 2026.

NEW YORK, Nov. 13, 2025 /PRNewswire/ -- Invictus Pharmacy, a pharmacist-founded and nationally licensed pharmacy network, announced today that it will begin accepting cryptocurrency as a form of payment from patients. This milestone makes Invictus Pharmacy the first nationwide licensed pharmacy to embrace digital assets as part of its patient payment infrastructure.

Continue Reading
This image opens in the lightbox
Invictus Ventures Management Logo

Beginning immediately, cryptocurrency payments including Ethereum (ETH), Solana (SOL), and XRP (Ripple) will be accepted at all Invictus Pharmacy retail locations. Starting January 1, 2026, patients will also be able to utilize these digital payment options through the company's online platform at InvictusPharmacy.com.

Key Benefits of Invictus Pharmacy's acceptance of cryptocurrency include:

  • Enhanced Security: Blockchain technology provides a secure and transparent platform for all transactions, reducing the risk of fraud.
  • Faster Transactions: Cryptocurrency transactions are typically faster than traditional payment methods, allowing for quicker processing of prescriptions.
  • Increased Accessibility: Accepting cryptocurrency opens up access to pharmaceutical services for younger demographics who prefer or are comfortable using digital currencies.
  • Transparency: Every transaction is recorded on the blockchain, creating a transparent and auditable trail.

Pioneering Transparency in the Pharmaceutical Payment System

This initiative represents the first phase of a larger technological movement led by Invictus Ventures Inc., the management company of Invictus Pharmacy. Invictus Ventures is developing a blockchain-based payment infrastructure designed specifically for the U.S. prescription drug market. The platform will facilitate instant, transparent, and auditable transactions between payers, manufacturers, pharmacies, and patients.

By accepting cryptocurrency payments, Invictus Pharmacy is also embracing the next generation of American consumers who are more comfortable and familiar with digital assets and alternative payment methods. This forward-looking approach reflects Invictus's commitment to modernizing the pharmacy experience, meeting patients where they are, and fostering financial accessibility through innovation.

By leveraging the power of blockchain technology, Invictus aims to eliminate the administrative lag and opacity that define today's pharmacy benefit model, replacing it with a real-time, programmable payment system that benefits every stakeholder in the chain.

"Pharmacy Benefit Managers (PBMs) were invented before the era of the internet to combat rising drug prices in the 1970s," said Meyer Davidoff, Founder and CEO of Invictus Pharmacy. "While their original purpose was to negotiate fair pricing and streamline reimbursements, PBMs have since evolved into powerful intermediaries that obscure true drug costs, delay payments to pharmacies, and inflate prices for patients. The system has become a labyrinth of rebates, clawbacks, and opaque contracts that benefit middlemen rather than patients or providers.

Today, PBMs act as central toll collectors in a system that should be moving toward openness and modern technology. Accepting cryptocurrency is more than offering another way to pay. It is the first step toward building a faster and more transparent payment network that links patients, pharmacies, and manufacturers with far fewer barriers. This is the future of pharmacy, a system where information and payments move quickly, clearly, and efficiently for everyone."

"For our patients, using cryptocurrency will feel just as simple as paying with a smartphone or credit card," said Alan Oustaev, Chief Operating Officer of Invictus Pharmacy. "Our goal is to make the experience seamless both in-store and online, giving patients more choice and convenience while we modernize how prescription payments are made."

An Open Call to Industry Partners

Invictus Pharmacy Founder and CEO Meyer Davidoff is encouraging trading partners throughout the pharmaceutical supply chain, including drug manufacturers, wholesalers, and payers, to begin adding cryptocurrency to their balance sheets and to explore digital asset integration within their financial infrastructure.

"This is the first step of our grand vision to revolutionize the archaic payment system within our industry," said Davidoff. "We are actively building an additional blockchain-based payment rail upon which all stakeholders, from manufacturers to patients, will transact seamlessly and transparently."

This forthcoming network, being developed under Invictus Ventures, will serve as a digital settlement layer for prescription transactions, enabling instant fund transfers, automated rebate validation, and frictionless reimbursement flows. Once fully deployed, the system is expected to reduce claim processing times from weeks to seconds, setting a new benchmark for efficiency in U.S. healthcare payments.

About Invictus Pharmacy

Invictus Pharmacy, managed by New York–based Invictus Ventures Inc., is a vertically integrated, nationwide pharmacy platform founded in 2017. With a network of retail locations, a licensed mail-order pharmacy, a proprietary e-commerce platform, and claims adjudication technology, Invictus has served more than one million patients. Invictus was among the first pharmacy organizations to adopt a Direct-to-Consumer (DTC) model for its manufacturing partners, enabling brands to reach patients directly while bypassing traditional intermediaries. By partnering directly with manufacturers to offer direct-to-consumer pricing and adding cryptocurrency payment options with blockchain-enabled claims transparency, Invictus lowers costs, expands access, and advances a next-generation pharmacy model.

Website: www.invictuspharmacy.com

Logo - https://mma.prnewswire.com/media/2781498/Invictus_Pharmacy_Logo.jpg
Logo - https://mma.prnewswire.com/media/2821966/Invictus_Ventures_Management_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • PR Newswire Amplify™
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.